NCCN Guidelines Insights: Uveal Melanoma, Version 1.2019

Area of Science:

• Ophthalmology
• Oncology

Background:

• Uveal melanoma is a rare eye cancer originating in the choroid or ciliary body.
• Distinguishing uveal melanoma from benign uveal nevi can be challenging, necessitating clear diagnostic criteria.
• The NCCN Guidelines provide a framework for managing uveal melanoma.

Purpose of the Study:

• To present updated NCCN Guidelines for uveal melanoma.
• To detail recommendations for staging, treatment, and follow-up of uveal melanoma.
• To provide guidance on differentiating uveal melanoma from benign nevi.

Main Methods:

• Review and synthesis of current evidence and expert consensus.
• Development of clinical algorithms for diagnosis and treatment.
• Inclusion of recommendations for workup of suspicious pigmented uveal lesions.

Main Results:

• Established criteria for distinguishing uveal melanoma from benign uveal nevi.
• Recommendations for workup, staging, and treatment of newly diagnosed nonmetastatic uveal melanoma.
• Guidance on follow-up and reevaluation for patients with uncertain diagnoses.

Conclusions:

• The NCCN Guidelines provide essential, evidence-based recommendations for uveal melanoma management.
• Accurate diagnosis and risk stratification are crucial for optimal patient outcomes.
• These guidelines support timely and appropriate treatment for uveal melanoma patients.